Declining use of percutaneous coronary intervention across population groups, 2011-2022

Vadim M Shteyler1,2, Jeffrey Tabas3, Jessica N Holtzman4

  • 1Division of Pulmonary, Critical Care, Allergy, and Sleep Medicine, University of California San Francisco, San Francisco, CA 94143, United States.

Health Affairs Scholar
|March 12, 2026
PubMed

Insights

Coronary revascularization rates, including percutaneous coronary interventions (PCI), have declined. Sociodemographic disparities in PCI utilization persist, indicating ongoing healthcare access differences.

Area of Science:

  • Cardiovascular medicine
  • Health services research
  • Public health

Background:

  • Coronary revascularization rates have decreased due to fewer acute coronary syndromes (ACS) and updated appropriate use criteria (AUC).
  • Population-based trends in utilization across sociodemographic groups remain understudied.

Purpose of the Study:

  • To analyze temporal trends in cardiac catheterizations and percutaneous coronary interventions (PCI) in California from 2011 to 2022.
  • To assess sociodemographic and facility-type disparities in PCI utilization.

Main Methods:

  • Utilized the Health Care Access and Information database for annual cardiac catheterization and PCI data.
  • Compared PCI shares of cardiac catheterizations across sociodemographic strata and facility types.
  • Employed regression models for trend analysis and pairwise comparisons for stratum differences.

Main Results:

  • Identified 1,839,444 cardiac catheterizations between 2011 and 2022.
  • Observed initial decreases in catheterizations and PCI (2011-2013), followed by a plateau, and another decrease in 2020.
  • Found higher PCI shares associated with higher income, private insurance, and White or Asian/Pacific Islander race compared to Black or Hispanic individuals.

Conclusions:

  • California's PCI share declined, likely due to reduced ACS and revised AUC for coronary revascularization.
  • The divergence in PCI versus overall catheterization trends suggests specific impacts on interventional procedures.
  • Persistent sociodemographic and payer-based disparities in PCI share highlight utilization heterogeneity, even after Medicaid expansion.
Abstract

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
358
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
486
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
792
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
373
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
374
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.4K